FDA Office of Hematology Oncology Products Reorganizes, Renamed Office of Oncologic Diseases

FDA Office of Hematology Oncology Products Reorganizes, Renamed Office of Oncologic Diseases

Summary

Office Renaming

Original reporting

Open original source

AFBytes is a read-only aggregator. Use the original source for full context and complete reporting.

Related coverage